On Monday morning, U.S. stock futures displayed a mixed outlook as investors remained cautious amid the ongoing Middle East conflict. The S&P 500 E-minis increased by 4.5 points (0.07%), and Nasdaq 100 E-minis rose by 75 points (0.31%), while Dow E-minis declined by 62 points (0.13%). Notably, shares of Soleno Therapeutics surged by approximately 40% after reports indicated that Neurocrine Biosciences was close to acquiring the company for over $2.5 billion. Additionally, U.S.-listed cryptocurrency firms experienced gains, with Coinbase and Strategy rising by 3.2% and 4%, respectively, as Bitcoin prices edged higher. The mixed performance of Wall Street's main indexes last Thursday, which marked their first weekly gains in six weeks, was influenced by the potential for a ceasefire in the Middle East. However, the prolonged closure of the Strait of Hormuz continues to exert pressure on energy prices and inflation concerns.